The largest database of trusted experimental protocols

Anti pe microbeads

Manufactured by Miltenyi Biotec
Sourced in Germany, United States, United Kingdom, Canada, Italy, Australia

Anti-PE microbeads are magnetic beads coated with antibodies that specifically bind to the phycoerythrin (PE) fluorescent label. These microbeads are designed for the separation and enrichment of PE-labeled cells or particles using magnetic separation techniques.

Automatically generated - may contain errors

357 protocols using anti pe microbeads

1

PBMC Isolation and pDC Depletion

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMC were separated from whole blood by Pancoll (PAN-Biotech, Cat# P04-60500) density gradient centrifugation. Sorting was performed using autoMACS Pro System (Miltenyi Biotech) according to manufacturer's instructions. PBMC were stained with CD14-PE antibody (Immunotools, Cat# 21620144, clone 18D11) followed by incubation with anti-PE microbeads (Miltenyi Cat# 130-048-801). The depleted fraction was collected and resuspended in R10 medium – i.e., RPMI 1640 (Sigma-Aldrich) containing 10% heat inactivated FBS (Sigma-Aldrich), 100 U/ml penicillin, 100 U/ml streptomycin and 2 mM L-glutamine (Life Technologies), 1 mM sodium pyruvate, 100 U/ml non-essential amino-acids, 50 μM 2-mercaptoethanol (Invitrogen). 5 × 105 cells/well were seeded in 96-well plates and stimulated with 20 µg/ml cGAMP or 1 µg/ml R848 (Invivogen France). For pDC depletion, PBMCs were stained with PE conjugated anti-BDCA4 (BioLegend Cat# 354504, RRID:AB_11219194) and anti-CD123 (BD Biosciences Cat# 555644, RRID:AB_396001) antibodies, and then sorted using anti-PE microbeads (Miltenyi) as above. Mock-depleted or pDC-depleted PBMCs were stimulated with R848 or ODN M362. Cell depletion was checked by flow cytometry on LSRII cytometer (BD Biosciences, RRID:SCR_002159). Supernatants were collected at 24 h and tested for IFNα by ELISA as described above.
+ Open protocol
+ Expand
2

Isolation of Tumor-Associated Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
We prepared single-cell suspensions from human lung tumors using the Tumor Dissociation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer’s instructions. Macrophages from these single-cell suspensions were magnetically sorted using primary antibodies, human CD68-PE (phycoerythrin) (Miltenyi Biotec) and secondary antibody, anti-PE MicroBeads (Miltenyi Biotec) according to the instructions provided by the manufacturer. Patient characteristics are shown in table S3. We fragmented mouse tumor tissues into small pieces, followed by digestion with collagenase (5 μg/μl) supplemented with deoxyribonuclease (DNase; 10 μg/μl) for 30 min at 37°C. Further, we passed the tissue extract through a cell strainer and treated it with red blood cell lysis buffer. Subsequently, we centrifuged and suspended cells in MACS buffer (Miltenyi Biotec, Bergisch Gladbach, Germany) supplemented with 5% BSA. We magnetically sorted macrophages from single-cell suspensions using the primary antibody F4/80-PE mouse (Miltenyi Biotec, Bergisch Gladbach, Germany) and the secondary antibody anti-PE MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany), according to the instructions provided by the manufacturers.
+ Open protocol
+ Expand
3

Generation and Enrichment of MR1-5-OP-RU Tetramers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using 5-OP-RU formed in situ from synthetic 5-A-RU and methylglyoxal, mouse and human MR1 tetramers were generated and biotinylated as previously described (50 –52 (link)). Biotinylated MR1–5-OP-RU monomers were tetramerized with streptavidin conjugated to either PE (SA-PE) (BD Pharmingen) or Brilliant Violet 421 (SA-BV) (Biolegend). Single cell suspensions of mouse thymus were prepared and stained with PE-mouse MR1–5-OP-RU tetramers prior to magnetic bead enrichment using anti-PE microbeads as per manufacturer’s instructions (Miltenyi Biotec). One independent enriched sample represents 2–3 pooled thymi unless otherwise specified. Single cell suspensions of human thymus were enriched for TRAV1.2+ cells by staining for TRAV1.2-PE antibody, followed by magnetic bead enrichment using anti-PE microbeads (Miltenyi Biotec).
+ Open protocol
+ Expand
4

Isolation and Characterization of Liver Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were sacrificed as per IACUC guidelines, and livers were perfused with 1X PBS (Lonza, Switzerland) and harvested. Tissues were processed by enzymatic digestion with 2mg/mL type IV collagenase (Worthington, NY) in serum-free media DMEM-F12 (Lonza). Following incubation, tissue digests were strained through sterile cheesecloth to remove particulate matter, and enzymatic reaction was quenched with complete media. Liver lymphocytes were isolated by Percoll or Ficoll-paque (GE, Sweden) gradients. CD4+ T cells were isolated by negative selection (STEM CELL). Where applicable, further positive selection of CD4+CD25+ T cells was performed using anti-CD25 PE (BD Biosciences) and anti-PE Microbeads (Miltenyi Biotec, CA). B cells were isolated using CD19-positive selection kit for both mouse and human studies (Miltenyi). Purity and composition was assessed on a BD LSRII Custom order system. Human liver interstitial mononuclear cell (LIMC) were isolated as described (14 (link)).
+ Open protocol
+ Expand
5

Modulation of B-Myeloid Cell Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
PB monocytes (isolated using the Human Monocyte Isolation Kit II, Miltenyi Biotec) or murine PC myeloid (depleted of B, T, and NK cells treated with mixture of anti-mouse CD19-PE, CD3-PE and DX5-PE Abs and anti-PE MicroBeads; Miltenyi Biotec) were mixed with eFluor® 450-labelled (5 μM; eBioscience) B cells from respective young subjects at a 1:1 ratio. To block BCR signaling, B cells were pre-treated with Btk (20 nM, PC1-32765; Selleckchem, Boston, MA) and SYK (4 μM, R406; Selleckchem) inhibitors for 30 min at 37 °C prior to mixing with myeloid cells. CD40 signaling was blocked with anti-mouse CD40L blocking Ab (10 μg/ml, clone MR1; eBioscience).
+ Open protocol
+ Expand
6

Characterization of KRAS-specific T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs from healthy donors, obtained from AllCells, were cultured and transduced with KRAS TCR or CAR constructs using custom lentivirus (Alstem) as described previously (15, 17 (link)). In the absence of enrichment, primary T cells were stained for TCR or CAR expression and pMHC probe binding similarly as described above for Jurkat cells. CD4 and CD8 T-cell populations were also characterized by flow cytometry. A total of 15 days posttransduction transduced primary T cells were enriched via positive selection by staining with protein L-biotin/streptavidin-PE or mTCRβ-PE followed by anti-PE microbeads (Miltenyi Biotec, 130-048-801) and subsequent separation through LS columns (Miltenyi Biotec). T cells were further expanded for 5 days and then cocultured with 25,000 target cells at an effector:target = 1:1 for 24 hours with peptide-pulsed T2 HLA-A*11, endogenous KRAS G12V(+) SHP77 ± HLA-A*11, or endogenous KRAS G12D(+)HLA-A*11(+) PANC-1. Secreted IFNγ in the culture was assessed by ELISA (Thermo Fisher Scientific, 88-7316-88).
+ Open protocol
+ Expand
7

Isolation of Plasmodium berghei Parasites

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the initial detection of LDV, P. berghei ANKA and P. berghei K173 stabilates were subjected to a mouse/rat comprehensive clear panel for PCR infectious agent testing (PRIA; Charles River). Further detection and quantitation of LDV particles were conducted with a simple PCR LDV test (Charles River) on mouse plasma.
To free P. berghei K173 blood from the virus, C57BL6/J mice were injected with 106P. berghei K173 pRBC; 10 days after injection, intracardiac blood was collected with heparin and washed with PBS. RBC and platelets were stained with anti-Ter119 (allophycocyanin [APC], REA847, 1/50; Miltenyi Biotec) and CD41 (PE, MWReg30, 1/300; BD Biosciences), and then RBC were separated from platelets by magnetic sorting using anti-PE microbeads (Miltenyi Biotec). The Ter119+ CD41 fraction was stained again with the same anti-Ter119 and CD41 antibodies, and RBC were FACS sorted with an Aria cell sorter (BD Biosciences). New B6 mice were injected with 106 sorted pRBC. Five days later, a new stock of pRBC was prepared as indicated above. Confirmation of the absence of LDV was performed by PCR (Charles River).
+ Open protocol
+ Expand
8

Isolation of FLK1+ EB Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Day 3.5/4 EB cells were stained with PE-conjugated FLK1 antibody (eBioscience) for 20 min. After a wash in PBS/FCS, cells were incubated with anti-PE microbeads (Miltenyi) for 15 min. FLK1+ cells were isolated on Myltenyi magnetic columns.
+ Open protocol
+ Expand
9

Single Cell Enrichment for MAIT and NKT

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions were prepared from thymus or spleen and incubated with PE-CD1d-PBS57 tetramer at 4°C or with PE-MR1–5–OP–RU tetramer at room temperature. Then anti-PE microbeads (Miltenyi) were used for immunomagnetic enrichment according to the manufacturer's instructions.
+ Open protocol
+ Expand
10

Isolation and Expansion of HBV-Specific CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs from human leukocyte antigen A (HLA‐A)*02‐positive (+) donors with chronic HBV infection were isolated through a standard Ficoll gradient. Informed consent in writing was obtained from each patient. PBMCs were stimulated by 10 μM of HBV core18‐27I peptide (FLPSDFFPSI; Sangon Biotech, Shanghai, China) for 10 days in X‐VIVO 15 (#04‐418QCN; Lonza) plus 10% human AB serum, 1% GlutMAX supplement (#35050061; Gibco), and penicillin‐streptomycin (#15140122; Gibco). We added 50 IU/mL interleukin (IL)‐2 (#200‐02; PEPROTECH), 10 ng/mL IL‐7 (#200‐07, PEPROTECH), and IL‐15 (#C016; Novoprotein) on day 1 and changed this solution every 2 days. T cells stained with R‐phycoerythrin (R‐PE)‐labeled Pro5 HLA‐A*02:01/FLPSDFFPSI pentamer (#F283‐2A‐G; Proimmune) were isolated by anti‐PE MicroBeads (#130‐105‐639; Miltenyi Biotec) according to the manufacturer’s protocol, followed by a rapid expansion protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!